SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-032118
Filing Date
2023-09-08
Accepted
2023-09-08 16:54:24
Documents
15
Period of Report
2023-09-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59265
2 ex10-01.htm EX-10.01 363598
3 ex99-01.htm EX-99.01 19657
4 ex99-01_001.jpg GRAPHIC 2387
  Complete submission text file 0001493152-23-032118.txt   698575

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pali-20230908.xsd EX-101.SCH 3024
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pali-20230908_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pali-20230908_pre.xml EX-101.PRE 22365
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3363
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 231245920
SIC: 2836 Biological Products, (No Diagnostic Substances)